Nicole M. Joy, MD

Cutaneous Insulin-Derived Amyloidosis Presenting as Hyperkeratotic Nodules

Publish date: January 20, 2021

Deposition of amyloid at insulin injection sites has the potential to interfere with insulin absorption, leading to poor glucose control.